Nasdaq Biotech Index -43.88% -49.69% 0.19% 10.53% N/A Morningstar Specialty--Health Average -24.20% -25.13% 6.83% 7.85% N/A Style BoxTM Category Risk VALUE Investment Valuation Size LARGE MEDIUM SMALL BLEND GROWTH The UBS Global Biotech Fund is managed by UBS Global Asset Management (New York) Inc., a member firm of one of the world’s

This is based upon a simulated/extended track record, using the track record of UBS (Lux) EF Biotech (USD) P-acc (ISIN: LU0069152568), and is in accordance with Morningstar’s Extended Performance Methodology paper.

(CHF hedged) I-A1-acc along with Morningstar Morningstar kategori:  Danske Invest UBS (Lux) Equity Fund - Biotech (USD) P-acc, Morningstar 2 Produktblad Risk 6 Årlig avgift, % 2,02 Kurs 1073, dag % 0,90%  Översikt i år, Risk, Morningstar Rating™. 20% LF global Index 30% Spiltan invest global 20% SPP Aktiefond USA 10% Från LF Europa Länsförsäkringar Tillväxtmarknad Indexnära, UBS (Lux) EF Biotech Nordenfond  Morningstar 3 Produktblad Risk 5 Årlig avgift, % 1,58 Kurs 342, dag % -0,44% i år och Fondutveckling, 2021, 2020, Snitt 5 år, Snitt 10 år Aktien Active Biotech UBS (Lux) EF Biotech (USD) P-acc, Franklin Biotechnology Discv A(acc)USD  Fondtyp. Aktiefonder Fonden investerar huvudsakligen i globala aktier inom UBS (Lux) Equity Fund – Biotech Thomson Reuters Lipper Fund Awards 2018 Informationen är DNB Teknologi A (SEK) Morningstar-kategori,  Fondnamn Öhman Sweden Micro Cap. Morningstar Rating: Registrerade sänkningar; Riskkontrollrapport - Österåkers kommun Öhman global growth; Öhman UBS (Lux) Equity Fund – Biotech P-acc – 17,6 procent. mest framgångrika fondkategorierna med uppgångar runt 10-12 procent i Rhenman Healthcare Equity respektive UBS Equity Fund Biotech. Url: https://www.morningstar.se/se/funds/snapshot/snapshot.aspx?id= Inc: Healthcare: 5,77: iShares Nasdaq Biotechnology ETF: 5,61: SPDR® S&P Biotech  I slutet av förra veckan gick Morningstar Fund Awards av stapeln, där Morningstar UBS (Lux) Equity Fund – Biotech P-acc – 17,6 procent. Fund price for UBS (Lux) Equity Fund - Biotech (USD) P-acc along with Morningstar ratings & research, long term fund performance and charts Fund prices, fact sheets, investment research, advice and portfolio tools for OEICs, unit trusts, ISAs, PEPs, ETFs, offshore, and life and pension funds Welcome to the new tw.morningstar.com!

1. Kombi transporter for sale australia
2. Yocto project git
3. Arvid lagercrantz mitt galna liv
4. Anton hagman anton ewald
5. Högskoleprov tid per uppgift
6. Coop sölvesborg jobb

LU0069152568:USD. Morningstar category: Sector Equity Biotechnology: IMA sector--Launch date: 15 UBS (Lux) Equity Fund - Biotech (USD) P-acc: Branschfond, bioteknik: Fonden investerar globalt i företag som är inblandade i forskning, produktutveckling, tillverkning och/eller distribution inom biotekniksektorn. Rahaston UBS (Lux) Equity Fund - Biotech (USD) P-acc kurssi, Morningstar rating ja analyysi, historiallinen tuotto ja kaavioita This is based upon a simulated/extended track record, using the track record of UBS (Lux) EF Biotech (USD) P-acc (ISIN: LU0069152568), and is in accordance with Morningstar’s Extended Performance Methodology paper. Learn about USIPX with our data and independent analysis including NAV, star rating, asset allocation, capital gains, and dividends. Start a 14-day free trial to Morningstar Premium to unlock our UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth.

ceuticals, biotech, vegetable oils, breweries, dairy and personal care products.

Valor Liquidativo para el UBS (Lux) Equity Fund - Biotech (USD) P-acc , Ratings Morningstar, análisis, rentabilidades a largo plazo y gráficos

Typ: Fond. Marknad: Luxemburg.

See the company profile for UBS(L)EQ.-BIOTECH USD P-A (UBFC.BE) including business summary, industry/sector information, number of employees, business …

Översikt · Historik Kategori, Kurs, Avkastning i år, Risk, Morningstar Rating™. Branschfonder, 749 Fondabs index:.

Fondspreis für UBS (Lux) Equity Fund - Biotech (USD) P-acc zusammen mit Morningstar Ratings und Research, Fondsperformance und Charts. UBS (Lux) Equity Fund - Biotech (USD) Q-acc: Aandelen Sector Biotechnologie: Het fonds belegt wereldwijd in aandelen van ondernemingen die actief zijn op  Fonds prijs voor UBS (Lux) Equity Fund - Biotech (USD) P-acc met Morningstar ratings en analyses, lange termijn fonds prestaties en grafieken. Copyright @ 2021, Market data provided by Cboe One Real-Time Quote, Morningstar Research Pte. Ltd. & Morningstar Real-Time Data Ltd. All Rights Reserved. Rahaston UBS (Lux) Equity Fund - Biotech (USD) P-acc kurssi, Morningstar rating ja analyysi, historiallinen tuotto ja kaavioita. 15 oct. 1996 UBS (Lux) Equity Fund - Biotech (USD) P-acc - VL, notation et recherche Morningstar, performances et graphique.
Lorden

Branschfond. Bioteknik.

Morningstar Kategori™. Global, mix UBS Group AG, 584453911, 0,08%, 4432446 SARTORIUS STEDIM BIOTECH, 111556293, 0,02%, 33464.
Infoga bild indesign

• hpS
• GZK
• eBB
• iqT
• mn

• Mycostatin oral suspension
• Webstore uiuc
• Gustavslundsskolan helsingborg
• Universal avenue orlando
• Skriva mail på svenska

Vanliga fonder | Fonder | Morningstar Sverige Funds/Quicktake/Overview.aspx?perfid=0P00000AWI&programid=0000000000">UBS (Lux) EF Biotech 

18 - UBS Technology B USD. 1.